Stock of the Day for October 29, 2024

DexCom Stock Report

DexCom
DXCM 90-day performance NASDAQ:DXCM DexCom
Current Price
$80.77
-8.29 (-9.31%)
(As of 04:00 PM ET)
30 Day Performance
-3.36%
  
  
90 Day Performance
-1.04%
  
  
1 Year Performance
19.09%
  
 
Market Capitalization
$31.67B
P/E Ratio
60.28
Price Target
$99.89
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

DXCM Company Calendar

JUL. 30, 2025
Last Earnings
JUL. 31, 2025
Today
DEC. 31, 2025
Fiscal Year End

Recent DexCom News

DexCom (NASDAQ:DXCM) Stock Price Expected to Rise, Barclays Analyst Says
Pacer Advisors Inc. Sells 11,767 Shares of DexCom, Inc. (NASDAQ:DXCM)
TD Asset Management Inc Sells 30,537 Shares of DexCom, Inc. (NASDAQ:DXCM)
Dexcom falls despite results beat, revenue outlook raise
DexCom’s (NASDAQ:DXCM) Q2 Sales Beat Estimates
DexCom’s (NASDAQ:DXCM) Q2 Sales Beat Estimates
DexCom, Inc. (DXCM) Q2 2025 Earnings Call Transcript
DexCom, Inc. 2025 Q2 - Results - Earnings Call Presentation
This report was written on July 31, 2025. This report first appeared on MarketBeat.com.